Rogalski, J. et al. 2024. Insights into risk factors of the Metabolic Dysfunction-Associated Steatotic Liver Disease development among patients with schizophrenia. Current Problems of Psychiatry. 25, (Nov. 2024), 226–238. DOI:https://doi.org/10.12923/2353-8627/2024-0021.